A defect in tyrosine aminotransferase, the first enzyme of the tyrosine degradation pathway, leads to hereditary tyrosinemia type 2 (HT2), also known as the Richner-Hanhart syndrome. Here, TAT is linked to Tyrosinemia type 2.